Kintegral Advisory’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$956K Sell
3,813
-169
-4% -$42K 0.09% 172
2025
Q4
$1.1M Sell
3,982
-109
-3% -$29.8K 0.09% 165
2025
Q3
$1.07M Sell
4,091
-18
-0.4% -$4.38K 0.09% 173
2025
Q2
$899K Sell
4,109
-6
-0.1% -$1.28K 0.08% 183
2025
Q1
$921K Sell
4,115
-13
-0.3% -$3.58K 0.09% 183
2024
Q4
$1.35M Sell
4,128
-192
-4% -$60.4K 0.13% 155
2024
Q3
$1.3M Sell
4,320
-57
-1% -$17.5K 0.12% 161
2024
Q2
$1.44M Sell
4,377
-6,736
-61% -$2.38M 0.14% 149
2024
Q1
$4.4M Sell
11,113
-35
-0.3% -$12.9K 0.44% 62
2023
Q4
$3.93M Sell
11,148
-71
-0.6% -$25.1K 0.43% 61
2023
Q3
$4.21M Sell
11,219
-7
-0.1% -$2.71K 0.52% 55
2023
Q2
$4.29M Hold
11,226
0.51% 55
2023
Q1
$3.89M Sell
11,226
-603
-5% -$176K 0.5% 59
2022
Q4
$2.78M Buy
+11,829
New +$2.8M 0.37% 91

Other funds holding WST